Tonghua Dongbao Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public, Subsidiary
- Established
- 1992-12-28
- Employees
- 3.1K
- Market Cap
- -
- Website
- http://www.thdb.com
Clinical Trials
9
Active:0
Completed:5
Trial Phases
3 Phases
Phase 1:5
Phase 2:1
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (55.6%)Phase 3
3 (33.3%)Phase 2
1 (11.1%)Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
Phase 2
Recruiting
- Conditions
- Overweight or Obese
- Interventions
- Drug: THDBH120 injectionDrug: Placebo of THDBH120 injection
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Target Recruit Count
- 276
- Registration Number
- NCT07036601
- Locations
- 🇨🇳
The Second Xiangya Hospital of Central South University, Changsha, China
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM
Phase 1
Completed
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Drug: THDBH120 injectionDrug: Placebo of THDBH120 injection
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Target Recruit Count
- 49
- Registration Number
- NCT07020949
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity
Phase 1
Completed
- Conditions
- Obesity
- Interventions
- Drug: THDBH120 injectionDrug: Placebo of THDBH120 injection
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT06951945
- Locations
- 🇨🇳
The First Affiliated Hospital of Bengbu Medical University, Anhui, China
🇨🇳Hangzhou First People's Hospital, Zhejiang, China
A Single- and Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of THDBH120 Injection in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: THDBH120 injection (SAD)Drug: Placebo of THDBH120 injection (SAD)Drug: THDBH120 injection (MAD)Drug: Placebo of THDBH120 injection (MAD)
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT06744868
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
Phase 3
Not yet recruiting
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: Insulin Degludec/liraglutide Injection
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Target Recruit Count
- 510
- Registration Number
- NCT06559722
- Prev
- 1
- 2
- Next
News
No news found